David Greenberg Sells 2,424 Shares of ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc. (NASDAQ:ICUI) Director David Greenberg sold 2,424 shares of the company’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total value of $297,933.84. Following the sale, the director owned 7,960 shares of the company’s stock, valued at $978,363.60. This trade represents a 23.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

ICU Medical Stock Down 1.0%

ICU Medical stock traded down $1.19 during midday trading on Wednesday, reaching $122.04. The company’s stock had a trading volume of 312,617 shares, compared to its average volume of 283,333. The stock’s 50-day simple moving average is $126.79 and its 200-day simple moving average is $138.45. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.34 and a quick ratio of 1.17. ICU Medical, Inc. has a 52-week low of $107.00 and a 52-week high of $160.29. The stock has a market capitalization of $3.05 billion, a P/E ratio of 65.97, a PEG ratio of 1.78 and a beta of 0.74.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, beating analysts’ consensus estimates of $1.78 by $0.19. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The company had revenue of $525.77 million during the quarter, compared to analysts’ expectations of $520.65 million. During the same period last year, the business posted $1.72 earnings per share. The firm’s revenue was down 12.3% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, sell-side analysts expect that ICU Medical, Inc. will post 6.31 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Piper Sandler decreased their price target on ICU Medical from $178.00 to $163.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a research note on Thursday, May 7th. Wall Street Zen upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Saturday. KeyCorp decreased their price target on ICU Medical from $180.00 to $164.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Finally, Weiss Ratings raised ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $169.00.

Institutional Trading of ICU Medical

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in ICU Medical by 3.4% during the fourth quarter. Vanguard Group Inc. now owns 2,714,746 shares of the medical instruments supplier’s stock worth $387,313,000 after acquiring an additional 89,755 shares during the period. Janus Henderson Group PLC grew its holdings in ICU Medical by 4.2% during the fourth quarter. Janus Henderson Group PLC now owns 2,576,756 shares of the medical instruments supplier’s stock worth $367,625,000 after acquiring an additional 103,220 shares during the period. Millennium Management LLC grew its holdings in ICU Medical by 173.4% during the third quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier’s stock worth $130,638,000 after acquiring an additional 690,694 shares during the period. Dimensional Fund Advisors LP grew its holdings in ICU Medical by 6.8% during the first quarter. Dimensional Fund Advisors LP now owns 983,802 shares of the medical instruments supplier’s stock worth $127,053,000 after acquiring an additional 63,026 shares during the period. Finally, State Street Corp grew its holdings in ICU Medical by 2.8% during the fourth quarter. State Street Corp now owns 942,670 shares of the medical instruments supplier’s stock worth $134,491,000 after acquiring an additional 25,545 shares during the period. 96.10% of the stock is owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.